| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Specific Location | Type |
|---|---|---|---|---|---|---|---|---|
| SELENOMETHIONINE | TOX-Non-Repro-Sublethal - organ/system effects | incidence of delayed hypersensitivity reactions to antigen versus controls | decreased | Controls = 24 Treated = 8 |
Adult | 12 weeks | Laboratory | Toxicity Factor Datasets |
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-Non-Repro-Sublethal - organ/system effects | blood monocyte counts after 78 days exposure versus controls | decreased | Controls = 24 Treated = 8 |
Adult | 12 weeks | Laboratory | Toxicity Factor Datasets |
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-Non-Repro-Sublethal - cellular/biochemical effects | serum ALT enzyme activity versus controls n high selenite and selenomethionine groups. | increased @ 3.5 mg/L (selenite) or 2.2 mg/L (selenomethionine) | Controls = 24 Treated = 8 |
Adult | 12 weeks | laboratory | Toxicity Factor Datasets |
| SELENOMETHIONINE | TOX-EXP IND - accumulation | selenium concentrations in pectoral muscle | increased (12-fold) | Controls = 24 Treated = 8 |
Adult | 12 weeks | Laboratory | Toxicity Factor Datasets |
